Sign in
4

Changes in Ownership

Lyell Immunopharma, Inc. Filed Acc 0001415889-25-016729

Options or other derivatives

  • General Counsel acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Meltz Mark A · General Counsel

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-06-09 Grant or award : show line 1 in the form Option (right to buy) +100,000 100,000 D
Loading xslF345X05/form4-06112025_090608.xml…